Diagnostic Code 8104 · 38 CFR §4.124a
Paramyoclonus multiplex — also called Friedreich myoclonus or essential myoclonus — is a rare neurological disorder characterized by sudden, brief, involuntary muscle jerks (myoclonus) affecting multiple muscle groups. The jerks can be isolated or repetitive, range from subtle twitches to violent whole-body movements, and typically occur without loss of consciousness or progression to other neurological disease. Some forms are familial; others are acquired after head trauma, encephalitis, toxic exposure, or as part of broader neurological syndromes including post-anoxic myoclonus, post-encephalitic myoclonus, and certain epilepsy syndromes. For veterans, the most relevant pathways are direct nexus to a service-related head injury, encephalitis, or toxic exposure, and aggravation of a premorbid condition. Treatment uses anticonvulsants (clonazepam, valproate, levetiracetam) and can substantially reduce but rarely eliminate the jerks. The VA rates DC 8104 based on the frequency and severity of the myoclonic movements and their functional impact.
| Rating | Criteria |
|---|---|
| 0% | Mild paramyoclonus — infrequent, subtle myoclonic jerks producing no functional impairment, controlled by medication or asymptomatic. |
| 10% | Moderate paramyoclonus — definite myoclonic jerks affecting multiple muscle groups, partial response to medication, occasional interference with activities such as eating, writing, or sustained tasks. |
| 30% | Moderately severe paramyoclonus — frequent disruptive myoclonic jerks, only partial response to medication, definite functional limitation in daily activity, occasional falls or dropped objects from limb jerks. |
| 60% | Severe paramyoclonus — refractory frequent myoclonic jerks, substantial functional impairment limiting ability to perform daily tasks, frequent falls or injury from jerks, or coexisting neurological deficits producing combined impairment. |
A neurology diagnosis distinguishing paramyoclonus multiplex from other myoclonic syndromes (epilepsy-related myoclonus, post-anoxic myoclonus, certain neurodegenerative diseases) is the anchor. Video documentation captures the movements when they are infrequent or subtle. EEG monitoring distinguishes cortical myoclonus from non-cortical forms and rules out concurrent epilepsy. Brain MRI rules out structural causes. Treatment records covering anticonvulsant trials demonstrate the management burden. Service treatment records establishing the in-service trigger event (head injury, encephalitis, toxic exposure) close the nexus.
No, though they share the myoclonic feature. Paramyoclonus multiplex (essential myoclonus) is a movement disorder without associated seizures, normal EEG between movements, and typically normal cognition. Myoclonic epilepsy (such as juvenile myoclonic epilepsy or progressive myoclonic epilepsies) involves myoclonus as part of a broader seizure syndrome with characteristic EEG abnormalities and often progressive cognitive decline. The conditions are rated under different codes — DC 8104 for paramyoclonus multiplex, DC 8910/8911 for myoclonic seizures — and EEG plus neurology consult distinguishes them.
Yes. Myoclonus developing after a service-connected head injury or anoxic event is a recognized post-traumatic neurological syndrome and supports secondary service connection. The nexus opinion typically frames the myoclonus as a residual of the underlying brain injury. Imaging and EEG help characterize whether the myoclonus has cortical, subcortical, or spinal origins, which affects treatment but not the rating framework.
A rating in continuous effect for five years or more is protected against reduction under 38 CFR §3.951 without strong evidence of sustained material improvement. Response to medication is not a basis for reduction; the underlying disorder is still present, and the medication produces the controlled state. Document continued movements (when not on medication, during medication adjustments, or during breakthrough periods) to support the rating.